ESC Premium Access

Novel Biomarkers for Early Risk Stratification in Acute Heart Failure

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Biomarkers
Session type: Advances in Science
Date: 31 August 2020
Time: 08:30 - 08:30

Congress Session

4 presentations in this session

State-of-the-art lecture in novel biomarkers for early risk stratification in acute heart failure.

Speaker: Professor A. Maisel (San Diego, US)
Thumbnail

Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure

Speaker: Doctor E. Michou (Basel, CH)
Thumbnail

Growth differentiation factor-15 significantly improves prognostication of short-term mortality in acute settings

Speaker: Ms K. Cerlinskaite-Bajore (Vilnius, LT)
Thumbnail

Prognostic performance of soluble urokinase plasminogen activator receptor for 1-year mortality in Asian and Western patients with acute breathlessness

Speaker: Doctor J. Chew-Harris (Christchurch, NZ)
Thumbnail

4 speakers from this session

Professor Alan Maisel

University of California, San Diego, San Diego (United States of America)
17 presentations
0 follower

Doctor Eleni Michou

University Hospital Basel, Basel (Switzerland)
0 follower

Ms Kamile Cerlinskaite-Bajore

Vilnius University, Vilnius (Lithuania)
0 follower

Doctor Janice Chew-Harris

University of Otago Christchurch, Christchurch (New Zealand)
0 follower

This platform is supported by

logo Novo Nordisk